3D BioOptima strives to best serve our clients with value-added solutions for their drug R&D programs of chemical and biological therapeutics by conducting specialized preclinical services, such as absorption, distribution, metabolism and excretion (ADME) characterization, pharmacokinetic and pharmacodynamic evaluation, bioanalysis, high-throughput ADME screening, ADME-assisted lead optimization, biological/pharmacological screening, large molecule research, exploratory toxicity assessment, and regulatory consultation.
| Website | http://www.3dbiooptima.com |
| Revenue | $5.3 million |
| Employees | 12 (3 on RocketReach) |
| Founded | 2007 |
| Address | 1338 Wuzhong Ave, Suzhou, Jiangsu, CN |
| Phone | +86 512 6768 3276 |
| Technologies |
JavaScript
,
HTML
,
PHP
+7 more
(view full list)
|
| Industry | Pharmaceutical Manufacturing, Industrial Machinery & Equipment, Manufacturing |
| Keywords | 3d Bioprinting, Preclinical Testing, Pharmacokinetics, Drug Discovery, Drug Development, Biopharmaceutical Services, Pharmaceutical Research, Therapeutic Development, Toxicology, Bioanalysis, Biotechnology, In Vitro Models, 3d Cell Culture, Clinical Trial Support |
| Competitors | Organogenesis, LIFECELL LIMITED, AVITA Medical, MediWound Ltd., Tissue Regenix Group, Collagen Solutions, CureMetrix, Lorem Cytori USA, Inc, InGeneron, Regenicin +29 more (view full list) |
| SIC | SIC Code 35 Companies, SIC Code 355 Companies |
| NAICS | NAICS Code 33 Companies, NAICS Code 333 Companies |
Looking for a particular 3D BioOptima employee's phone or email?
The 3D BioOptima annual revenue was $5.3 million in 2026.
Kaiyang Tang is the Associate Director Of Operations of 3D BioOptima.
3 people are employed at 3D BioOptima.
3D BioOptima is based in Suzhou, Jiangsu.
The NAICS codes for 3D BioOptima are [33, 333].
The SIC codes for 3D BioOptima are [35, 355].